{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:35:31Z","timestamp":1792200931350,"version":"4.4.0"},"reference-count":204,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-25-00190"],"award-info":[{"award-number":["22-25-00190"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jconrel.2022.05.046","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T05:09:17Z","timestamp":1654664957000},"page":"264-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases"],"prefix":"10.1016","volume":"348","author":[{"given":"Niloufar","family":"Rahiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya V.","family":"Markina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.05.046_bb0005","doi-asserted-by":"crossref","first-page":"A259","DOI":"10.1016\/j.autrev.2009.12.002","article-title":"Definition of human autoimmunity\u2014autoantibodies versus autoimmune disease","volume":"9","author":"Lleo","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fimmu.2019.00672","article-title":"Complement therapeutics in autoimmune disease","volume":"10","author":"Thurman","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/BOR.0000000000000574","article-title":"The microbiome in systemic autoimmune disease--mechanistic insights from recent studies","volume":"31","author":"Dehner","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/eji.201747059","article-title":"Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseases","volume":"48","author":"Serra","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nri702","article-title":"Cytokines and autoimmunity","volume":"2","author":"O\u2019Shea","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0030","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/90935","article-title":"Autoimmune disease: why and where it occurs","volume":"7","author":"Marrack","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","article-title":"Multistep pathogenesis of autoimmune disease","volume":"130","author":"Goodnow","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJM200103013440907","article-title":"Tolerance and autoimmunity","volume":"344","author":"Kamradt","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0045","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cellimm.2018.09.008","article-title":"Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells","volume":"339","author":"Kumar","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0060","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.2174\/0929867327666201111145212","article-title":"Anti-tumor effects of curcuminoids in glioblastoma multiforme: an updated literature review","volume":"28","author":"Afshari","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.phrs.2017.12.020","article-title":"Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: a clinical review","volume":"130","author":"Bagherniya","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0070","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1002\/jcp.27442","article-title":"Curcumin as an anti-inflammatory agent: implications to radiotherapy and chemotherapy","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.autrev.2017.11.016","article-title":"Curcumin: A natural modulator of immune cells in systemic lupus erythematosus","volume":"17","author":"Momtazi-Borojeni","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0080","first-page":"567","article-title":"Short-term curcuminoid supplementation for chronic pulmonary complications due to sulfur mustard intoxication: positive results of a randomized double-blind placebo-controlled trial","volume":"65","author":"Panahi","year":"2015","journal-title":"Drug Res. (Stuttg)"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctim.2017.05.006","article-title":"Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial","volume":"33","author":"Panahi","year":"2017","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.phrs.2018.09.012","article-title":"Therapeutic potential of curcumin in diabetic complications","volume":"136","author":"Parsamanesh","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0095","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1002\/jcp.27404","article-title":"Curcumin: a naturally occurring autophagy modulator","volume":"234","author":"Shakeri","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.leu.2403233","article-title":"Role of curcumin and the inhibition of NF-$\u03ba$ B in the onset of chemotherapy-induced mucosal barrier injury","volume":"18","author":"Van\u2019t Land","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10875-006-9066-7","article-title":"\u201cSpicing up\u201d of the immune system by curcumin","volume":"27","author":"Jagetia","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155541","article-title":"Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled trials","volume":"143","author":"Gorabi","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0115","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.autrev.2019.05.012","article-title":"Targeting the balance of T helper cell responses by curcumin in inflammatory and autoimmune states","volume":"18","author":"Rahimi","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/biom9020056","article-title":"Formulations of curcumin nanoparticles for brain diseases","volume":"9","author":"Prado-Audelo","year":"2019","journal-title":"Biomolecules."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0125","series-title":"Mol. Targets Ther. Uses Curcumin Heal. Dis.","first-page":"425","article-title":"Curcumin and autoimmune disease","author":"Bright","year":"2007"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5455\/njppp.2016.6.3005201596","article-title":"Curcumin and its protective and therapeutic uses","volume":"6","author":"Agrawal","year":"2016","journal-title":"Nat. J. Physiol. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0135","first-page":"369","article-title":"Curcumin: a promise of native chemoprevention agent that need to be fulfilled in clinical trials","volume":"4","author":"Bar-Sela","year":"2011","journal-title":"Int. J. Cancer Res. Prev."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic roles of curcumin: lessons learned from clinical trials","volume":"15","author":"Gupta","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2018.08.004","article-title":"Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): formulation development, characterization and pharmacological evaluation","volume":"290","author":"Kesharwani","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0150","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/jcm9020430","article-title":"Curcumin\u2019s nanomedicine formulations for therapeutic application in neurological diseases","volume":"9","author":"Salehi","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.phanu.2020.100226","article-title":"Curcumin: a therapeutic potential in ageing-related disorders","volume":"14","author":"Vaiserman","year":"2020","journal-title":"PharmaNutrition."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0160","first-page":"1","article-title":"Review on nanoformulations of curcumin (Curcuma longa Linn.): special emphasis on nanocurcumin\u00ae","volume":"3","author":"Islam","year":"2019","journal-title":"Int. J. Nat. Life Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejps.2009.02.019","article-title":"Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer","volume":"37","author":"Shaikh","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0170","article-title":"Protective effect of curcumin nanoparticles against cardiotoxicity induced by doxorubicin in rat","volume":"1866","author":"Mohammed","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0175","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.2147\/IJN.S210320","article-title":"Nano encapsulated curcumin: and its potential for biomedical applications","volume":"15","author":"Chen","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0180","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013007236","article-title":"Nanocurcumin: a promising therapeutic advancement over native curcumin","volume":"30","author":"Flora","year":"2013","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0185","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/1568009618666181016152042","article-title":"Oral drug delivery systems for ulcerative colitis therapy: a comparative study with microparticles and nanoparticles","volume":"19","author":"Ma","year":"2019","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0190","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.2147\/IJN.S170832","article-title":"Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles","volume":"13","author":"Sun","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2015.10.049","article-title":"Nanoparticles and nanofibers for topical drug delivery","volume":"240","author":"Goyal","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0200","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0205","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2217\/nnm.12.80","article-title":"Advances in nanotechnology-based delivery systems for curcumin","volume":"7","author":"Sun","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0210","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0215","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.3390\/ijms21145053","article-title":"Topical delivery of curcumin by choline-calix [4] arene-based nanohydrogel improves its therapeutic effect on a psoriasis mouse model","volume":"21","author":"Filippone","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0220","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.046_bb0225","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/jid.2011.259","article-title":"Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands","volume":"132","author":"Morizane","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2017.07.007","article-title":"Psoriasis: a mixed autoimmune and autoinflammatory disease","volume":"49","author":"Liang","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0240","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/jfmpc.jfmpc_689_19","article-title":"Update on psoriasis: a review","volume":"9","author":"Rajguru","year":"2020","journal-title":"J. Fam. Med. Prim. Care."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0245","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3389\/fimmu.2019.01764","article-title":"Adaptive and innate immunity in psoriasis and other inflammatory disorders","volume":"10","author":"Sch\u00f6n","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0250","first-page":"218","article-title":"Use of curcumin in psoriasis, open access maced","volume":"6","author":"Di Nardo","year":"2018","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0255","article-title":"Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0260","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/jphp.12611","article-title":"Curcumin as potential therapeutic natural product: a nanobiotechnological perspective","volume":"68","author":"Shome","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0265","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.intimp.2012.03.025","article-title":"Curcumin induces apoptosis in tumor necrosis factor-alpha-treated HaCaT cells","volume":"13","author":"Sun","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s13671-019-0248-y","article-title":"Nanotechnology for psoriasis therapy","volume":"8","author":"Murphy","year":"2019","journal-title":"Curr. Dermatol. Rep."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-021-00401-3","article-title":"Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist","volume":"22","author":"Li","year":"2021","journal-title":"BMC Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-39903-x","article-title":"Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice","volume":"9","author":"Horv\u00e1th","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0285","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3390\/polym12102393","article-title":"Preparation and evaluation of collagen-based patches as curcumin carriers","volume":"12","author":"Terzopoulou","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0290","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2017.03.385","article-title":"Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel","volume":"254","author":"Sun","year":"2017","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.046_bb0295","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.apsb.2020.11.008","article-title":"Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model","volume":"11","author":"Lin","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0300","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.colsurfb.2017.10.029","article-title":"Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model","volume":"160","author":"Mao","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0305","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3390\/molecules24071388","article-title":"Synergistic effects of photo-irradiation and curcumin-chitosan\/alginate nanoparticles on tumor necrosis factor-alpha-induced psoriasis-like proliferation of keratinocytes","volume":"24","author":"Gomez","year":"2019","journal-title":"Molecules."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.046_bb0310","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40199-020-00352-x","article-title":"Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis","volume":"28","author":"Iriventi","year":"2020","journal-title":"Daru J. Fac. Pharm. Tehran Univ. Med. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0315","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/pharmaceutics11120639","article-title":"Mechanistic evaluation of enhanced curcumin delivery through human skin in vitro from optimised nanoemulsion formulations fabricated with different penetration enhancers","volume":"11","author":"Yousef","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0320","article-title":"Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis","volume":"59","author":"Algahtani","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0325","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3390\/biom10070968","article-title":"Co-delivery of imiquimod and curcumin by nanoemugel for improved topical delivery and reduced psoriasis-like skin lesions","volume":"10","author":"Algahtani","year":"2020","journal-title":"Biomolecules."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0330","first-page":"1","article-title":"Novel nanoemulsion gel containing triple natural bio-actives combination of curcumin, thymoquinone, and resveratrol improves psoriasis therapy: in vitro and in vivo studies","author":"Khatoon","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0335","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/03639045.2020.1793998","article-title":"Systematic development and characterization of curcumin-loaded nanogel for topical application","volume":"46","author":"Kesharwani","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0340","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/exd.12696","article-title":"Effect of new curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses","volume":"24","author":"Esposito","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0345","doi-asserted-by":"crossref","first-page":"105438","DOI":"10.1016\/j.ejps.2020.105438","article-title":"Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin[1] V.K. Rapalli, V. Kaul, T. Waghule, S. Gorantla, S. Sharma, A. Roy, S.K. Dubey, G","volume":"152","author":"Rapalli","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0350","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.biomaterials.2018.08.030","article-title":"Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice","volume":"182","author":"Kang","year":"2018","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0355","doi-asserted-by":"crossref","first-page":"150","DOI":"10.22159\/ijap.2021v13i3.40668","article-title":"Boosting the skin delivery of curcumin through stearic acid-ethyl cellulose blend hybrid nanocarriers-based approach for mitigating psoriasis","author":"Jaiswal","year":"2021","journal-title":"Int. J. Appl. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0360","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1039\/D1TB00557J","article-title":"Enhanced transdermal efficiency of curcumin-loaded peptide-modified liposomes for highly effective antipsoriatic therapy","volume":"9","author":"Yu","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0365","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/thno.29715","article-title":"CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified ethosomes: A new strategy for clustering drug in inflammatory skin","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0370","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2016.10.004","article-title":"Tacrolimus and curcumin co-loaded liposphere gel: synergistic combination towards management of psoriasis","volume":"243","author":"Jain","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0375","doi-asserted-by":"crossref","first-page":"66745","DOI":"10.1039\/C6RA13851A","article-title":"Encapsulation of curcumin over carbon dot coated TiO 2 nanoparticles for pH sensitive enhancement of anticancer and anti-psoriatic potential","volume":"6","author":"Sawant","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0380","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/life11070651","article-title":"Study of skin barrier function in psoriasis: the impact of emollients","volume":"11","author":"Maroto-Morales","year":"2021","journal-title":"Life."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119101","article-title":"Enhanced penetration and anti-psoriatic efficacy of curcumin by improved smartPearls technology with the addition of glycyrrhizic acid","volume":"578","author":"Jin","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0390","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jphp.12910","article-title":"Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels","volume":"70","author":"Bilia","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0395","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12974-019-1517-1","article-title":"Impact of B cells to the pathophysiology of multiple sclerosis","volume":"16","author":"Arneth","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0400","first-page":"9108","article-title":"Curcumin prevents experimental autoimmune encephalomyelitis by inhibiting proliferation and effector CD4+ T cell activation","volume":"23","author":"Liu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0405","series-title":"Curcumin Neurol. Psychiatr. Disord.","first-page":"365","article-title":"Curcumin impact on multiple sclerosis","author":"Qureshi","year":"2019"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0410","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1871530319666181129103056","article-title":"Molecular mechanisms of curcumin in neuroinflammatory disorders: a mini review of current evidences","volume":"19","author":"Hatami","year":"2019","journal-title":"Endocrine Metab. Immun. Disord. Targets"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0415","first-page":"1267","article-title":"Curcumin ameliorates oxidative stress in animal models of multiple sclerosis","volume":"9","author":"Mavaddatiyan","year":"2019","journal-title":"J. Fasa Univ. Med. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0420","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.expneurol.2013.12.016","article-title":"Curcumin protects axons from degeneration in the setting of local neuroinflammation","volume":"253","author":"Tegenge","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0425","doi-asserted-by":"crossref","first-page":"12237","DOI":"10.1002\/jcp.27965","article-title":"Curcumin as a therapeutic candidate for multiple sclerosis: molecular mechanisms and targets","volume":"234","author":"Ghanaatian","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0430","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.intimp.2010.08.013","article-title":"Curcumin has bright prospects for the treatment of multiple sclerosis","volume":"11","author":"Xie","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0435","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10072-017-3149-5","article-title":"Therapeutic potential of curcumin for multiple sclerosis","volume":"39","author":"Qureshi","year":"2018","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0440","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4274\/tjps.galenos.2018.90522","article-title":"Phytotherapy as a complementary medicine for multiple sclerosis","volume":"16","author":"Rabiei","year":"2019","journal-title":"Turk. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0445","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.intimp.2009.01.025","article-title":"Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production","volume":"9","author":"Xie","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0450","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/biof.1533","article-title":"Benefits of curcumin in brain disorders","volume":"45","author":"Bhat","year":"2019","journal-title":"BioFactors."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0455","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1080\/17425247.2021.2003327","article-title":"An insight into the role of liposomal therapeutics in the reversion of multiple sclerosis","volume":"18","author":"Rahiman","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0460","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jconrel.2022.02.009","article-title":"Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis","volume":"343","author":"Rahiman","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0465","series-title":"Dendrosomal Nano-Curcumin, the Novel Formulation to Improve the Anticancer Properties of Curcumin","author":"TAHMASEBI","year":"2015"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0470","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2015.07.013","article-title":"Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair","volume":"99","author":"Mohajeri","year":"2015","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0475","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/term.3110","article-title":"Dendrosomal nanocurcumin promotes remyelination through induction of oligodendrogenesis in experimental demyelination animal model","volume":"14","author":"Motavaf","year":"2020","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0480","first-page":"310","article-title":"Protective effects of a nano-formulation of curcumin against cuprizone-induced demyelination in the mouse corpus callosum","volume":"19","author":"Motavaf","year":"2020","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2018.03.018","article-title":"Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lyolecithin-induced focal demyelination model of rat corpus callosum","volume":"674","author":"Naeimi","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0490","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11095-016-2080-4","article-title":"In vitro modulation of TrkB receptor signaling upon sequential delivery of curcumin-DHA loaded carriers towards promoting neuronal survival","volume":"34","author":"Guerzoni","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0495","article-title":"Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis","volume":"119987","author":"Lu","year":"2020","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0500","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/mt.2011.164","article-title":"Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain","volume":"19","author":"Zhuang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0505","first-page":"1","article-title":"Conjugated linoleic acid-curcumin attenuates cognitive deficits and oxidative stress parameters in the ethidium bromide--induced model of demyelination","author":"Barzegarzadeh","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0510","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1002\/jcp.26301","article-title":"Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial","volume":"233","author":"Dolati","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0515","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.intimp.2018.05.018","article-title":"Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis","volume":"61","author":"Dolati","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0520","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.pharep.2018.05.008","article-title":"Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators","volume":"70","author":"Dolati","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jneuroim.2019.01.007","article-title":"Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis","volume":"327","author":"Dolati","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0530","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejpb.2019.01.012","article-title":"Potential therapeutic effect of curcumin loaded hyalurosomes against inflammatory and oxidative processes involved in the pathogenesis of rheumatoid arthritis: the use of fibroblast-like synovial cells cultured in synovial fluid","volume":"136","author":"Manca","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0535","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144098","article-title":"Are key cytokines genetic and serum levels variations related to rheumatoid arthritis clinical severity?","volume":"722","author":"de Lima","year":"2020","journal-title":"Gene."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0545","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0550","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","article-title":"Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis","volume":"15","author":"Chen","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0555","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.intimp.2019.04.027","article-title":"Curcumin attenuates collagen-induced rat arthritis via anti-inflammatory and apoptotic effects","volume":"72","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0560","series-title":"Immunomodulatory Effects of Curcumin in Rheumatoid Arthritis: Evidence from Molecular Mechanisms to Clinical Outcomes","author":"Haftcheshmeh","year":"2020"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0565","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3390\/ijms21072299","article-title":"The emerging role of curcumin in the modulation of TLR-4 signaling pathway: focus on neuroprotective and anti-rheumatic properties","volume":"21","author":"Panaro","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0570","first-page":"365","article-title":"Curcumin induces apoptosis and inhibits prostaglandin E2 production in synovial fibroblasts of patients with rheumatoid arthritis","volume":"20","author":"Park","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0575","first-page":"273","article-title":"Curcumin: a review for health benefits","volume":"7","author":"Rathore","year":"2020","journal-title":"Int. J. Res. Rev."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0580","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10067-012-2041-1","article-title":"Advances in research on animal models of rheumatoid arthritis","volume":"32","author":"Hu","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0585","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/08923973.2018.1434793","article-title":"Experimental animal models for rheumatoid arthritis","volume":"40","author":"Choudhary","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0590","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.2147\/IJN.S219413","article-title":"Co-delivery of prednisolone and curcumin in human serum albumin nanoparticles for effective treatment of rheumatoid arthritis","volume":"14","author":"Yan","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0595","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s10753-019-01021-1","article-title":"Co-nanoencapsulation of vitamin D 3 and curcumin regulates inflammation and purine metabolism in a model of arthritis","volume":"42","author":"da Silva","year":"2019","journal-title":"Inflammation."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0600","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jddst.2017.07.022","article-title":"Preparation, characterization and anti-inflammatory effects of curcumin loaded carboxymethyl cellulose acetate butyrate nanoparticles on adjuvant induced arthritis in rats","volume":"41","author":"Dewangan","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0605","doi-asserted-by":"crossref","first-page":"23595","DOI":"10.1021\/acsami.8b06236","article-title":"Anti-inflammation and joint lubrication dual effects of a novel hyaluronic acid\/curcumin nanomicelle improve the efficacy of rheumatoid arthritis therapy","volume":"10","author":"Fan","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0610","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jcis.2011.11.014","article-title":"Co-delivery of antigen and a lipophilic anti-inflammatory drug to cells via a tailorable nanocarrier emulsion","volume":"368","author":"Chuan","year":"2012","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0615","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijpharm.2016.04.052","article-title":"Emu oil based nano-emulgel for topical delivery of curcumin","volume":"506","author":"Jeengar","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0620","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.2147\/IJN.S82788","article-title":"Curcumin-loaded colloidal carrier system: formulation optimization, mechanistic insight, ex vivo and in vivo evaluation","volume":"10","author":"Naz","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0625","first-page":"852","article-title":"Proniosomal formulation of curcumin having anti-inflammatory and anti-arthritic activity in different experimental animal models","volume":"67","author":"Kumar","year":"2012","journal-title":"Die Pharm. Int. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0630","first-page":"4931","article-title":"The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats","volume":"9","author":"Zheng","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0635","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ejp.620","article-title":"Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats","volume":"19","author":"Arora","year":"2015","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0640","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/08916934.2020.1846184","article-title":"Nanostructured lipid carrier-based smart gel: a delivery platform for intra-articular therapeutics","volume":"54","author":"Shinde","year":"2021","journal-title":"Autoimmunity."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0645","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.intimp.2018.10.039","article-title":"Liposomes encapsulated dimethyl curcumin regulates dipeptidyl peptidase I activity, gelatinase release and cell cycle of spleen lymphocytes in-vivo to attenuate collagen induced arthritis in rats","volume":"65","author":"Sun","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0650","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/pharmaceutics13040454","article-title":"Liposomal nanosystems in rheumatoid arthritis","volume":"13","author":"Ferreira-Silva","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0655","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.4049\/jimmunol.0802972","article-title":"Antigen-specific suppression of inflammatory arthritis using liposomes","volume":"182","author":"Capini","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0660","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/1756-185X.13688","article-title":"Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double-blind, controlled trial","volume":"22","author":"Javadi","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0665","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0670","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0675","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5217\/ir.2018.16.1.26","article-title":"Immunological pathogenesis of inflammatory bowel disease","volume":"16","author":"Lee","year":"2018","journal-title":"Intest. Res."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0680","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2174\/138161209788489177","article-title":"Curcumin has bright prospects for the treatment of inflammatory bowel disease","volume":"15","author":"Hanai","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0685","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2022.05.046_bb0690","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/jmf.2020.0129","article-title":"Effects of the use of curcumin on ulcerative colitis and Crohn\u2019s disease: a systematic review","volume":"24","author":"Goulart","year":"2021","journal-title":"J. Med. Food"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0695","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1745-7254.2006.00322.x","article-title":"Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis","volume":"27","author":"Zhang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0700","doi-asserted-by":"crossref","first-page":"21127","DOI":"10.3390\/molecules191221127","article-title":"Curcumin and inflammatory bowel disease: potential and limits of innovative treatments","volume":"19","author":"Vecchi Brumatti","year":"2014","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0705","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.drudis.2016.03.007","article-title":"Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease","volume":"21","author":"Sreedhar","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0710","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/jgh.14911","article-title":"Efficacy of adjuvant curcumin therapy in ulcerative colitis: A meta-analysis of randomized controlled trials","volume":"35","author":"Zheng","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0715","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1017\/S0007114509992510","article-title":"Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1$\u03b2$ and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease","volume":"103","author":"Epstein","year":"2010","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0720","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1089\/jmf.2017.0146","article-title":"Is curcumin a possibility to treat inflammatory bowel diseases?","volume":"21","author":"Mazieiro","year":"2018","journal-title":"J. Med. Food"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0725","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5152\/tjg.2019.18342","article-title":"Curcumin ameliorates dextran sulfate sodium-induced colitis in mice via regulation of autophagy and intestinal immunity","volume":"30","author":"Yue","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0730","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molimm.2020.11.016","article-title":"Curcumin and inflammatory bowel diseases: from in vitro studies to clinical trials","volume":"130","author":"Fallahi","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0735","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000336720","article-title":"Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication","volume":"85","author":"Ali","year":"2012","journal-title":"Digestion."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0740","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/nu8010044","article-title":"Therapeutic potential to modify the mucus barrier in inflammatory bowel disease","volume":"8","author":"Sun","year":"2016","journal-title":"Nutrients."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0745","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijbiomac.2020.09.214","article-title":"Natural proteins and polysaccharides in the development of micro\/nano delivery systems for the treatment of inflammatory bowel disease","volume":"165","author":"Shah","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0750","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.3390\/ijms21113956","article-title":"Natural product-based nanomedicine in treatment of inflammatory bowel disease","volume":"21","author":"Khare","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0755","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2014.07.009","article-title":"Pr\u00e9at, pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease","volume":"473","author":"Beloqui","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0760","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1039\/D0TB02092C","article-title":"Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues","volume":"9","author":"Huang","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0765","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2018.12.046","article-title":"Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy","volume":"557","author":"Chen","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110880","article-title":"Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics","volume":"187","author":"Zhou","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0775","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jddst.2019.04.030","article-title":"Mucus-penetrating polymeric nanoparticles for oral delivery of curcumin to inflamed colon tissue","volume":"52","author":"Zhou","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0780","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1039\/C7TB00328E","article-title":"Oral delivery of curcumin via porous polymeric nanoparticles for effective ulcerative colitis therapy","volume":"5","author":"Chen","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0785","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msec.2017.07.037","article-title":"Preparation, characterization and anti-colitis activity of curcumin-asafoetida complex encapsulated in turmeric nanofiber","volume":"81","author":"Gopi","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0790","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biomaterials.2019.05.012","article-title":"Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis","volume":"212","author":"Gou","year":"2019","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2021.101089","article-title":"Colonic macrophage-targeted curcumin nanoparticles alleviate DSS-induced colitis in mice through the NF-kappa B pathway","volume":"41","author":"Liu","year":"2021","journal-title":"Food Biosci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115126","article-title":"Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery","volume":"223","author":"Zhang","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0805","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1080\/10717544.2021.1934189","article-title":"An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0810","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10717544.2016.1245367","article-title":"Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease","volume":"24","author":"Qiao","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0815","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/21691401.2018.1442345","article-title":"Augmentation of therapeutic potential of curcumin using nanotechnology: current perspectives","volume":"46","author":"Sivasami","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185999","article-title":"Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells","volume":"12","author":"Ohno","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0825","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1021\/acs.nanolett.9b04841","article-title":"Enhanced transport of shape and rigidity-tuned $\u03b1$-lactalbumin nanotubes across intestinal mucus and cellular barriers","volume":"20","author":"Bao","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.127241","article-title":"Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis","volume":"330","author":"Luo","year":"2020","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0835","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2014.01.056","article-title":"Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice","volume":"146","author":"Xiao","year":"2014","journal-title":"Gastroenterology."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0840","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijbiomac.2015.11.092","article-title":"Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin","volume":"86","author":"Mutalik","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0845","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.15710","article-title":"Combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation","volume":"6","author":"Xiao","year":"2016","journal-title":"Theranostics."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0850","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0855","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jps.23828","article-title":"pH-sensitive nanoparticles of curcumin--celecoxib combination: evaluating drug synergy in ulcerative colitis model","volume":"103","author":"Gugulothu","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0860","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1021\/acs.biomac.0c00589","article-title":"Curcumin nanocrystal\/pH-responsive polyelectrolyte multilayer core--shell nanoparticles for inflammation-targeted alleviation of ulcerative colitis","volume":"21","author":"Oshi","year":"2020","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0865","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.colsurfb.2016.05.038","article-title":"Mucoadhesive microparticulates based on polysaccharide for target dual drug delivery of 5-aminosalicylic acid and curcumin to inflamed colon","volume":"145","author":"Duan","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0870","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.7150\/thno.38081","article-title":"Orally deliverable nanotherapeutics for the synergistic treatment of colitis-associated colorectal cancer","volume":"9","author":"Han","year":"2019","journal-title":"Theranostics."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0875","doi-asserted-by":"crossref","first-page":"20809","DOI":"10.1039\/C8RA01898G","article-title":"Biodistribution and targeting potential assessment of mucoadhesive chitosan nanoparticles designed for ulcerative colitis via scintigraphy","volume":"8","author":"Raj","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0880","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/pharmaceutics9030024","article-title":"Multiple functions of D-$\u03b1$-tocopherol polyethylene glycol 1000 succinate (TPGS) as curcumin nanoparticle stabilizer: in vivo kinetic profile and anti-ulcerative colitis analysis in animal model","volume":"9","author":"Rachmawati","year":"2017","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0885","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.colsurfb.2016.03.038","article-title":"A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease","volume":"143","author":"Beloqui","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0890","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijpharm.2015.05.008","article-title":"Curcumin--piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy","volume":"490","author":"Li","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0895","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2147\/IJN.S191337","article-title":"Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin","volume":"14","author":"Hou","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119533","article-title":"Ascorbyl-dipalmitate-stabilised nanoemulsions as a potential localised treatment of inflammatory bowel diseases","volume":"586","author":"Plaza-Oliver","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0905","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11130-016-0587-9","article-title":"Transepithelial transport of curcumin in Caco-2 cells is significantly enhanced by micellar solubilisation","volume":"72","author":"Frank","year":"2017","journal-title":"Plant Foods Hum. Nutr."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0910","article-title":"Enhancing stability and anti-inflammatory properties of curcumin in ulcerative colitis therapy using liposomes mediated colon-specific drug delivery system","volume":"112123","author":"Wang","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0915","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/21691401.2018.1543191","article-title":"Improved uptake and therapeutic intervention of curcumin via designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorder","volume":"47","author":"Sharma","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"8","key":"10.1016\/j.jconrel.2022.05.046_bb0920","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/MCG.0000000000001416","article-title":"Novel bioenhanced curcumin with Mesalamine for induction of clinical and endoscopic remission in mild-to-moderate ulcerative colitis: a randomized double-blind placebo-controlled pilot study","volume":"55","author":"Banerjee","year":"2020","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0925","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1002\/jcb.27273","article-title":"The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients\u2019 self-reported well-being: A randomized double-blind controlled trial","volume":"119","author":"Masoodi","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0930","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127057","article-title":"Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes","volume":"10","author":"Pujol-Autonell","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0935","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0940","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","article-title":"Type I diabetes mellitus","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0945","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0950","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.fct.2015.05.022","article-title":"The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update","volume":"83","author":"Ghosh","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0955","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/antiox4040662","article-title":"Identification and antioxidant activity of the extracts of Eugenia uniflora leaves. Characterization of the anti-inflammatory properties of aqueous extract on diabetes expression in an experimental model of spontaneous type 1 diabetes (NOD mice)","volume":"4","author":"Schumacher","year":"2015","journal-title":"Antioxidants."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0960","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036079","article-title":"The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice","volume":"7","author":"Davoodi-Semiromi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0965","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102843","article-title":"Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes","volume":"9","author":"Plesner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0970","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/bph.13816","article-title":"Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus","volume":"174","author":"Ganugula","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0975","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jff.2017.06.023","article-title":"Encapsulation in chitosan-based polyelectrolyte complexes enhances antidiabetic activity of curcumin","volume":"35","author":"Akolade","year":"2017","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.jconrel.2022.05.046_bb0980","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jddst.2019.05.020","article-title":"Preparation and characterization of CS-ZnO-NC nanoparticles for imparting anti-diabetic activities in experimental diabetes","volume":"52","author":"Chauhan","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110688","article-title":"Curcumin nanoparticles have potential antioxidant effect and restore tetrahydrobiopterin levels in experimental diabetes","volume":"131","author":"Abu-Taweel","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0990","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1751-7176.2011.00434.x","article-title":"Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection","volume":"13","author":"Long","year":"2011","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.jconrel.2022.05.046_bb0995","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.3390\/app11125497","article-title":"Multi-organ protective effects of curcumin nanoparticles on drug-induced acute myocardial infarction in rats with Type 1 Diabetes Mellitus","volume":"11","author":"Boarescu","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.jconrel.2022.05.046_bb1000","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s13346-011-0041-3","article-title":"Protective effects of nanoparticulate coenzyme Q 10 and curcumin on inflammatory markers and lipid metabolism in streptozotocin-induced diabetic rats: a possible remedy to diabetic complications","volume":"1","author":"Devadasu","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2022.05.046_bb1005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/adt.2018.902","article-title":"Coadministration of polypeptide-k and curcumin through solid self-nanoemulsifying drug delivery system for better therapeutic effect against diabetes mellitus: formulation, optimization, biopharmaceutical characterization, and pharmacodynamic assessment","volume":"17","author":"Garg","year":"2019","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.jconrel.2022.05.046_bb1010","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13470","article-title":"Protective effect of pristine C60 fullerene nanoparticle in combination with curcumin against hyperglycemia-induced kidney damage in diabetes caused by streptozotocin","volume":"44","author":"Demir","year":"2020","journal-title":"J. Food Biochem."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.046_bib1011","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5114\/aoms.2020.93739","article-title":"Effects of free and nanoparticulate curcumin on chemically induced liver carcinoma in an animal model (2021)","volume":"17","author":"Mohammed","year":"2021","journal-title":"Archives of Medical Science"},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.046_bib1012","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MOH.0000000000000389","article-title":"The regulation and importance of monocyte chemoattractant protein-1","volume":"25","author":"Bianconi","year":"2018","journal-title":"Current Opinion in Hematology"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:26:01Z","timestamp":1759163161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922003182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":204,"alternative-id":["S0168365922003182"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.046","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}